Janice Christensen

Janice Christensen is an experienced legal professional specializing in regulatory counsel within the biopharmaceutical industry. Currently serving as Regulatory Counsel for Neuroscience at AbbVie since August 2024, following the acquisition of Cerevel Therapeutics, where Janice held the position of Lead Regulatory Counsel from March 2022 to August 2024. Prior to Cerevel, Janice worked as Regulatory Counsel at Viatris from November 2020 to March 2022, and previously within the Upjohn division of Pfizer from May 2020 to November 2020. Janice has also held positions as Founding Partner at Jellins Christensen LLP, Counsel at Alston & Bird LLP, and Associate at Morgan & Finnegan LLP. Janice earned a J.D. from Fordham University School of Law in 2002.